Abstract
Corrigendum to “Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer” [Canc. Lett. 438 (2018, Dec 1) 165–173
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have